193 evolution "https:" "https:" "https:" "https:" "https:" "https:" "UCL" positions at King's College London
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
biomedical computing at the School of Biomedical Engineering & Imaging Sciences. The work will be done in close collaboration with a multidisciplinary team at KCL, UCL and clinicians at Great Ormond Street
-
of EDI, learning and development (L&D) and organisational change within our large and complex Faculty. Working closely with the Faculty’s Vice Dean for People and Culture, the role holder will be
-
development, with a particular emphasis on the choroid plexus and cerebrospinal fluid in development, ageing, and disease. The Centre for Developmental Neurobiology is a leading research centre located in
-
. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies
-
development fellowships, with eligibility for an open‑ended position at King’s upon securing such an award. About the role To be successful in this role you need to be able to show a body of research outputs
-
-omics, radiology images, and clinical text, are demonstrating exceptional performance in drug discovery and clinical tasks. Yet their development is hindered by data access, fragmentation, harmonisation
-
development and implementation of compliance strategies tailored to the diverse needs of the campus environment. Promote a culture of safety, accountability, and continuous improvement within the engineering
-
: The Build Director will oversee the design, development and implementation of software applications within the university. This role is crucial in ensuring that the University's applications support Student
-
31st May 2027 with a possibility of an extension. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat
-
for helping to continue the successful delivery and future development of ongoing epilepsy research projects funded by the UK Epilepsy Research Institute, Medical Research Council and Angelini Pharma